课题基金 / 基金详情

Interaction of RSK2 with 5-HT2A receptor

Interaction of RSK2 with 5-HT2A receptor
RSK2 与 5-HT2A 受体的相互作用
批准号:
6659665
负责人:
DOUGLAS J SHEFFLER
金额:
$3.54万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2004-11-30

项目摘要

项目成果

DOUGLAS J SHEFFLER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):拟定研究的目的是验证RSK 2与酵母双杂交筛选中鉴定的5-HT 2A受体第三胞内环的相互作用。一旦建立了这种相互作用,将确定其功能意义。我们的中心假设是RSK 2与5-HT 2A受体相互作用,表明在信号转导中的作用。这种相互作用可能在5-HT 2A受体对MAP激酶级联的配体依赖性激活中起作用。RSK 2基因中的失活突变是人类Coffin-Lowry综合征的原因。这种综合征的特征是严重的非特异性精神发育迟滞、精神病和进行性骨骼变形。Coffin-Lowry综合征中存在的精神病可能被证明归因于5-HT 2A信号传导功能障碍。为了测试这个中心思想,我们建议通过共免疫沉淀研究和共聚焦显微镜研究来验证5-HT 2A受体的第三胞内环和RSK 2的相互作用。RSK 2与5-HT 2A受体的结合位点将通过定点诱变研究结合双杂交分析来确定。RSK 2和5-HT 2A受体之间相互作用的功能作用将被定义。
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed research is to verify the interaction of RSK2 with the third intracellular loop of the 5-HT2A receptor that was identified in a yeast-2-hybrid screen. Once this interaction has been established, its functional significance will be determined. Our central hypothesis is that RSK2 interacts with the 5-HT2A receptor, indicating a role in signal transduction. It is likely that this interaction plays a role in the ligand-dependent activation of the MAP Kinase cascade by the 5-HT2A receptor. Inactivating mutations in the RSK2 gene are responsible for the human Coffin-Lowry syndrome. This syndrome is characterized by severe non-specific mental retardation, psychosis, and progressive skeletal deformations. The psychosis that is present in Coffin-Lowry syndrome may prove to be attributed to a disfunction of 5-HT2A signaling. To test this central idea we propose to verify the interaction of the 5-HT2A receptor's third intracellular loop and RSK2 via coimmunoprecipitation studies and through confocal microscopy studies. The binding site of RSK2 to the 5-HT2A receptor will be defined via site-directed mutageneis studies in conjunction with 2-hybrid analysis. The functional role of the interaction between RSK2 and the 5-HT2A receptor will be defined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
Interaction of RSK2 with 5-HT2A receptor
  • 批准号:
    6585422
  • 项目类别:
  • 资助金额:
    $3.28万
  • 财政年份:
    2002
  • 负责人:
    DOUGLAS J SHEFFLER
  • 依托单位:
国内基金
海外基金
靶向RSK2增强IGF1R抑制剂抗三阴性乳腺癌转移的机制研究
  • 批准号:
    2025JJ50641
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    于晓晖
  • 依托单位:
RSK2调控ERBB4的转录促进ER阳性乳腺癌他莫昔芬耐药的机制研究
  • 批准号:
    2023JJ40952
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    姜世龙
  • 依托单位:
TIMP3介导的RSK2信号通路在乳腺癌转移中的作用及机制
  • 批准号:
    2023JJ60414
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    陈宗林
  • 依托单位:
RSK2通过HDAC3/DUSP5元件调控皮肤纤维化病变的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    金利泰
  • 依托单位: